BDBM323189 N-[(R)-2-(3-butoxy-3-phenylazetidin-1-yl)-1-cyclohexylmethyl-2-oxoethyl]-3-(1H-imidazol-4-yl)propionamide::US9630949, 18

SMILES CCCCOC1(CN(C1)C(=O)[C@@H](CC1CCCCC1)NC(=O)CCc1c[nH]cn1)c1ccccc1

InChI Key InChIKey=NNWVZNRNABAESJ-RUZDIDTESA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 323189   

TargetMelanocortin receptor 4(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323189(N-[(R)-2-(3-butoxy-3-phenylazetidin-1-yl)-1-cycloh...)
Affinity DataEC50:  8.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323189(N-[(R)-2-(3-butoxy-3-phenylazetidin-1-yl)-1-cycloh...)
Affinity DataEC50:  8.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent